InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the complete record of transactions filed by Gupta Suneel, Directeur. Director active across 1 company, notably Protagonist Therapeutics, Inc. Aggregated, 10 filings have been recorded. History available since 15 February 2022. The latest transaction was filed on 25 November 2024 (Levée d'options). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Gupta Suneel
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations10 total
45,000 shares@ US$7.3835.3% of flowCommon StockSEC:0001104659-24-123807:0
4,282 shares@ US$29.5313.0% of flowCommon StockSEC:0001104659-24-028886:0
5,000 shares@ US$7.383.8% of flowCommon StockSEC:0001104659-24-003435:0
19,250 shares0Common StockSEC:0001104659-24-001495:0
20,000 shares@ US$7.3815.5% of flowCommon StockSEC:0001104659-23-110803:0
12,000 shares0Common StockSEC:0001104659-23-067691:0
20,625 shares0Common StockSEC:0001104659-23-004730:0
40,000 shares@ US$7.380.0051% mcap95.2% of flowCommon StockSEC:0001104659-22-050560:0
649 shares@ US$24.280.0003% mcap4.8% of flowCommon StockSEC:0001104659-22-029522:0
12,500 shares0Common StockSEC:0001104659-22-024838:0
10 of 10 declarations
About Gupta Suneel
Suneel Gupta serves as the Chief Development Officer at Protagonist Therapeutics, Inc. In this role, he is responsible for leading strategic development and innovation initiatives within the company. His expertise in the biotechnology field contributes to the advancement of research and development projects.
